OLIGOSOL Potassium S oral in ampoule 28Amp/2ml

Oral solution.
Ampoule with two self-breaking tips of 2 ml. Box of 28.

For one ampoule of 2 ml:

Potassium gluconate: 0,240 mg
(Corresponding quantity of potassium: 0,040 mg)

Excipient with known effect: glucose (100 mg in one ampoule of 2 ml).

Used as a terrain modifier, particularly during functional muscular manifestations and cramps.

Dosage

FOR ADULTS ONLY.

1 to 3 ampoules per day.

The ampoules are to be taken:

• preferably in the morning on an empty stomach,
• possibly 15 minutes before a meal or in the evening at bedtime.

Method of administration

Oral use.

Sublingual administration is recommended: keep the contents of the ampoule under the tongue for 1 to 2 minutes before swallowing.

Hypersensitivity to the active substance or to any of the excipients listed in section Composition.

When potassium supplementation is indicated (hypokalaemia or risk of hypokalaemia), potassium in the form of a trace element is not suitable.

This medicine contains glucose. Its use is not recommended in patients with glucose-galactose malabsorption syndrome (a rare hereditary disease).

The data available to date do not suggest the existence of clinically significant interactions.

In the absence of experimental and clinical data, and as a precaution, use of this medicine should be avoided during pregnancy and breastfeeding.

POTASSIUM OLIGOSOL, oral solution in ampoule has no effect on the ability to drive vehicles or use machines.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr.

No cases of overdose have been reported.

Pharmacotherapeutic class: OLIGOTHERAPY (V: various).

Trace mineral element.

5 years.

Store at a temperature not exceeding 25 °C.

No special requirements.